AB 1841: Student safety: opioid overdose reversal medication: student housing facilities.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2024-09-29
Current Status:
Passed
(2024-09-29: Chaptered by Secretary of State - Chapter 942, Statutes of 2024.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified.
The bill would require the governing board of each community college district and the Trustees of the California State University to notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of opioid overdose reversal medication and that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training. The bill would require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term. The bill would also require the governing board of each community college district and the Trustees of the California State University to require each campus health center located on a campus within their respective segments to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility, to be maintained by the housing facility, fraternity, or sorority in an accessible location, as provided. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential advisor, resident, or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. The bill would also require each residential advisor and house manager to receive opioid overdose prevention and treatment training, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified.
The bill would require the governing board of each community college district and the Trustees of the California State University to notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of opioid overdose reversal medication and that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training. The bill would require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term. The bill would also require the governing board of each community college district and the Trustees of the California State University to require each campus health center located on a campus within their respective segments to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility, to be maintained by the housing facility, fraternity, or sorority in an accessible location, as provided. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential advisor, resident, or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. The bill would also require each residential advisor and house manager to receive opioid overdose prevention and treatment training, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified. Existing law requests that the Regents of the University of California comply with these requirements.
The bill would require the governing board of each community college district and the Trustees of the California State University to notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and to medication and that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training. The bill would require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term. The bill would also require the governing board of each community college district and the Trustees of the California State University to require each campus health center located on a campus within their respective segments to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to each university- or college-affiliated student housing facility, to be maintained by the university- or college-affiliated student housing facility, as provided. The bill would require the governing board of each community college district and the Trustees of the California State University to also distribute 2 doses to facility and each university- or college-affiliated fraternity or sorority facility, to be maintained by the fraternity or housing facility, fraternity, or sorority in an accessible location, as provided. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential advisor, resident, or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. The bill would also require each residential advisor and house manager to receive opioid overdose prevention and treatment training, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program. The bill would request that the Regents of the University of California comply with these requirements.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified. Existing law requests that the Regents of the University of California comply with these requirements.
The bill would require the governing board of each community college district and the Trustees of the California State University to notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and to require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term. The bill would also require the governing board of each community college district and the Trustees of the California State University to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to residential advisors who work in a each university- or college-affiliated student housing facility, and to house managers who work in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members, and 4 additional doses, located at each residential housing office front desk, for a residential advisor to resupply as needed. to be maintained by the university- or college-affiliated student housing facility, as provided. The bill would require the governing board of each community college district and the Trustees of the California State University to also distribute 2 doses to each university- or college-affiliated fraternity or sorority facility, to be maintained by the fraternity or sorority in an accessible location, as provided. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential advisor advisor, resident, or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. The bill would also require each residential advisor and house manager to receive opioid overdose prevention and treatment training, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program. The bill would request that the Regents of the University of California comply with these requirements.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified. Existing law requests that the Regents of the University of California comply with these requirements.
The bill would require the governing board of each community college district and the Trustees of the California State University to notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to residential advisers advisors who work in a university- or college-affiliated student housing facility, and to house managers who work in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members. members, and 4 additional doses, located at each residential housing office front desk, for a residential advisor to resupply as needed. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential adviser advisor or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. The bill would also require each residential advisor and house manager to receive opioid overdose prevention and treatment training, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program. The bill would request that the Regents of the University of California comply with these requirements.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified. Existing law requests that the Regents of the University of California comply with these requirements.
The bill would require the governing board of each community college district and the Trustees of the California State University to require each university or college-affiliated student-housing facility to stock federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as specified, train all residential staff members at each university or college-affiliated student-housing facility on the administration of the opioid overdose reversal medication, as provided, and distribute the opioid overdose reversal medication to all university or college-affiliated Greek-life housing facilities, as specified. notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and to distribute, at the beginning of each academic semester or term, 2 doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project to residential advisers who work in a university- or college-affiliated student housing facility, and to house managers who work in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members. The bill would prohibit disciplinary measures from being imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where a residential adviser or house manager administers a dose of a federally approved opioid overdose reversal medication, as provided. By imposing new duties on community college districts, the bill would constitute a state-mandated local program. The bill would request that the Regents of the University of California comply with these requirements.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
Existing law requires the governing board of each community college district and the Trustees of the California State University, in collaboration with campus-based and community-based recovery advocacy organizations, to provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments, and to notify students of the presence and location of fentanyl test strips, as specified. Existing law requires the governing board of each community college district and the Trustees of the California State University to require that each campus health center apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services, distribute, upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as provided, and stock and distribute fentanyl test strips, as specified. Existing law requests that the Regents of the University of California comply with these requirements.
The bill would require the governing board of each community college district and the Trustees of the California State University to require each university or college-affiliated student-housing facility to stock federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project, as specified, train all residential staff members at each university or college-affiliated student-housing facility on the administration of the opioid overdose reversal medication, as provided, and distribute the opioid overdose reversal medication to all university or college-affiliated Greek-life housing facilities, as specified. By imposing new duties on community college districts, the bill would constitute a state-mandated local program. The bill would request that the Regents of the University of California comply with these requirements.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
SEC. 2.Section 67384.5 is added to the Education Code, to read:67384.5.(a)The governing board of each community college district and the Trustees of the California State University shall do all of the following:
(1)Notify students, by sending an email at the beginning of each academic semester or term, that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(2)Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
(3)Require that each campus health center located on a campus within their respective segments distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility.
(4)Require each university- or college-affiliated student housing facility to maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.
(5)Require each university- or college-affiliated fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.
(6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receives opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
(b)The institutions primary concern in implementing paragraphs (4) and (5) of subdivision (a) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the residential advisor or house manager, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
SEC. 2.Section 67384.5 is added to the Education Code, to read:67384.5.(a)The governing board of each community college district and the Trustees of the California State University shall do all of the following:
(1)Notify students, by sending an email at the beginning of each academic semester or term, that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(2)Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
(3)Require that each campus health center located on a campus within their respective segments distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility.
(4)Require each university- or college-affiliated student housing facility to maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.
(5)Require each university- or college-affiliated fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.
(6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receives opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
(b)The institutions primary concern in implementing paragraphs (4) and (5) of subdivision (a) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the residential advisor or house manager, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do all both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication. medication.
(3)Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(4)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each university- or college-affiliated student housing facility.(B)Each university- or college-affiliated student housing facility shall maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.(C)The institutions primary concern in implementing subparagraph (B) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential advisor, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.(5)(A) Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each university- or college-affiliated fraternity or sorority facility.(B)Each university- or college-affiliated fraternity or sorority facility shall maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.(C)The institutions primary concern in implementing subparagraph (B) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the house manager, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions. (6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receive opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.SEC. 2.Section 67384.5 is added to the Education Code, to read:67384.5.(a)The governing board of each community college district and the Trustees of the California State University shall do all of the following:
(1)Notify students, by sending an email at the beginning of each academic semester or term, that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(2)Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
(3)Require that each campus health center located on a campus within their respective segments distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility.
(4)Require each university- or college-affiliated student housing facility to maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.
(5)Require each university- or college-affiliated fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.
(6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receives opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
(b)The institutions primary concern in implementing paragraphs (4) and (5) of subdivision (a) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the residential advisor or house manager, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
SEC. 2.SEC. 3.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both all of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication, and that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication.
(3)Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(4)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each residential advisor, or the equivalent position, who works in a university- or college-affiliated student housing facility, to have in their room, and while on call, on their person, and four additional doses, located at each residential housing office front desk, for a residential advisor, or the equivalent position, to resupply as needed. university- or college-affiliated student housing facility.
(B)Subparagraph (A) does not require a residential advisor, or the equivalent position, who works in a university- or college-affiliated student housing facility to administer a federally approved opioid overdose reversal medication.(B)Each university- or college-affiliated student housing facility shall maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.
(C)The institutions primary concern in implementing subparagraph (A) (B) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential advisor, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(5)(A) Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members, to have in their room, and while on call, on their person. facility.
(B)Subparagraph (A) does not require a house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members to administer a federally approved opioid overdose reversal medication.(B)Each university- or college-affiliated fraternity or sorority facility shall maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.
(C)The institutions primary concern in implementing subparagraph (A) (B) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the house manager, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receive opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips and opioid overdose reversal medication. medication, and that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(4)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each residential adviser, advisor, or the equivalent position, who works in a university- or college-affiliated student housing facility, to have in their room, and while on-call, on call, on their person. person, and four additional doses, located at each residential housing office front desk, for a residential advisor, or the equivalent position, to resupply as needed.
(B)Subparagraph (A) does not require a residential adviser, advisor, or the equivalent position, who works in a university- or college-affiliated student housing facility to administer a federally approved opioid overdose reversal medication.
(C)The institutions primary concern in implementing subparagraph (A) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential adviser, advisor, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(5)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members, to have in their room, and while on-call, on call, on their person.
(B)Subparagraph (A) does not require a house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members to administer a federally approved opioid overdose reversal medication.
(C)The institutions primary concern in implementing subparagraph (A) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the house manager, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(6)(A)Ensure that each residential advisor and each house manager, or the equivalent positions, receive opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
(B)The training required by subparagraph (A) shall include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, shall inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify Notify, by sending an email at the beginning of each academic semester or term, students of the presence and location of fentanyl test strips through a method such as email. and opioid overdose reversal medication.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(c)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require each university or college-affiliated student-housing facility to stock federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.(d)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, train all residential staff members at each university or college-affiliated student-housing facility on the administration of opioid overdose reversal medication obtained through the Naloxone Distribution Project. The training shall include, but is not limited to, all of the following:(1)Instruction on uses of the opioid overdose reversal medication.(2)Instruction on the administration techniques for the opioid overdose reversal medication.(3)Instruction on the methods for recognizing opioid overdose.(e)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, distribute opioid overdose reversal medication obtained through the Naloxone Distribution Project to all university or college-affiliated Greek-life housing facilities, including any fraternity or sorority facility that provides housing to its student members.(4)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each residential adviser, or the equivalent position, who works in a university- or college-affiliated student housing facility, to have in their room, and while on-call, on their person.
(B)Subparagraph (A) does not require a residential adviser, or the equivalent position, who works in a university- or college-affiliated student housing facility to administer a federally approved opioid overdose reversal medication.
(C)The institutions primary concern in implementing subparagraph (A) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential adviser, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(5)(A)Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions, to each house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members, to have in their room, and while on-call, on their person.
(B)Subparagraph (A) does not require a house manager, or the equivalent position, who works in a university- or college-affiliated fraternity or sorority facility that provides housing to its student members to administer a federally approved opioid overdose reversal medication.
(C)The institutions primary concern in implementing subparagraph (A) shall be student safety. Disciplinary measures shall not be imposed for any violation of the institutions student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of the incident where the house manager, or the equivalent position, administers a dose of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
(a)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, do both of the following:
(1)In collaboration with campus-based and community-based recovery advocacy organizations, provide, as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and information about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses of their respective segments.
(2)Notify students of the presence and location of fentanyl test strips through a method such as email.
(b)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require that each campus health center located on a campus within their respective segments do all of the following:
(1)Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication, and to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services.
(2)Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(3)Stock fentanyl test strips in the campus health center and distribute the fentanyl test strips through the campus health center. Written instructions on how to properly use the fentanyl test strips shall be distributed together with the fentanyl test strips.
(c)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, require each university or college-affiliated student-housing facility to stock federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
(d)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, train all residential staff members at each university or college-affiliated student-housing facility on the administration of opioid overdose reversal medication obtained through the Naloxone Distribution Project. The training shall include, but is not limited to, all of the following:
(1)Instruction on uses of the opioid overdose reversal medication.
(2)Instruction on the administration techniques for the opioid overdose reversal medication.
(3)Instruction on the methods for recognizing opioid overdose.
(e)The governing board of each community college district and the Trustees of the California State University shall, and the Regents of the University of California are requested to, distribute opioid overdose reversal medication obtained through the Naloxone Distribution Project to all university or college-affiliated Greek-life housing facilities, including any fraternity or sorority facility that provides housing to its student members.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
|
Date
|
Status
|
|---|---|
| Sep 29, 2024 | Chaptered by Secretary of State - Chapter 942, Statutes of 2024. |
| Sep 29, 2024 | Approved by the Governor. |
| Sep 5, 2024 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 27, 2024 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 77. Noes 0.). |
| Aug 27, 2024 | Assembly Rule 77 suspended. |
| Aug 26, 2024 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 28 pursuant to Assembly Rule 77. |
| Aug 26, 2024 | Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0.). |
| Aug 20, 2024 | Read second time. Ordered to third reading. |
| Aug 19, 2024 | Read third time and amended. Ordered to second reading. |
| Aug 19, 2024 | Read second time. Ordered to third reading. |
| Aug 15, 2024 | From committee: Do pass. (Ayes 6. Noes 0.) (August 15). |
| Aug 5, 2024 | In committee: Referred to APPR suspense file. |
| Jun 20, 2024 | From committee: Do pass and re-refer to Com. on APPR with recommendation: To Consent Calendar. (Ayes 11. Noes 0.) (June 19). Re-referred to Com. on APPR. |
| Jun 10, 2024 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. |
| May 29, 2024 | From committee: Do pass and re-refer to Com. on HEALTH. (Ayes 7. Noes 0.) (May 29). Re-referred to Com. on HEALTH. |
| May 20, 2024 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on ED. |
| May 1, 2024 | Referred to Coms. on ED. and HEALTH. |
| Apr 18, 2024 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Apr 18, 2024 | Read third time. Passed. Ordered to the Senate. (Ayes 72. Noes 0.) |
| Apr 11, 2024 | Read second time. Ordered to Consent Calendar. |
| Apr 10, 2024 | From committee: Do pass. To Consent Calendar. (Ayes 14. Noes 0.) (April 10). |
| Mar 13, 2024 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (March 12). Re-referred to Com. on APPR. |
| Mar 7, 2024 | Re-referred to Com. on HIGHER ED. |
| Mar 6, 2024 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HIGHER ED. Read second time and amended. |
| Jan 29, 2024 | Referred to Com. on HIGHER ED. |
| Jan 17, 2024 | From printer. May be heard in committee February 16. |
| Jan 16, 2024 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 27, 2024 | AB 1841 Weber Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 26, 2024 | Assembly 3rd Reading AB1841 Weber By Hurtado | Senate Floor |
Passed |
|
| Aug 15, 2024 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 5, 2024 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 19, 2024 | Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar | Senate Standing Committee on Health |
Passed |
|
| May 29, 2024 | Do pass, but first be re-referred to the Committee on [Health] | Senate Standing Committee on Education |
Passed |
|
| Apr 18, 2024 | AB 1841 Weber Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Apr 10, 2024 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| Mar 12, 2024 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Higher Education |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| California Academy Of Family Physicians | ** Support | |
| California Alliance Of Child And Family Services | ** Support | |
| California Association of Alcohol and Drug Program Executives | ** Support | |
| California Chiropractic Association | ** Support | |
| California District Attorneys Association | ** Support | |
| California Federation Of Teachers | ** Support | |
| California Society of Health System Pharmacists | ** Support | |
| California Teachers Association | ** Support | |
| Faculty Association Of California Community Colleges | ** Support | |
| Generation Up | ** Support | |
| Indivisible Ca: Statestrong | ** Support | |
| Solano County Democratic Central Committee | ** Support |
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 1841
Author:(Weber)
As Amended Ver:August 19, 2024
Majority vote
SUMMARY
Requires health centers on campus of the California Community College (CCC) and California State University (CSU) to provide two doses of opioid overdose reversal medication to each housing facilities and sorority and fraternity housing on campus and establishes the opioid overdose reversal medication training and notification requirements for students, residential advisors, and house managers on CCC and CSU campuses.
Senate Amendments
- Requires each campus of the CCC and CSU, and requests each campus of the University of California to notify students by email each academic semester or term the location of fentanyl test strips and opioid overdose reversal medication on campus;
- Establishes a new code section on the provision and training for the use opioid overdose reversal medication to read as follows:
- Requires the CCC and CSU to send an email at the beginning of each semester or term to students informing them that each residential advisor and house manager has received opioid overdose reversal prevention and treatment training;
- Requires the CCC and CSU to train all students who live on campus on how to use the opioid overdose reversal medication during student orientation;
- Requires the campus health centers to provide two doses of opioid overdose reversal medication to each student housing facility and fraternity or sorority facility;
- Requires the student housing facility and the fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an assessable location and that each residential advisor or house manager is aware of the location of the medication;
- Requires that each residential advisor and each house manager receive training on the use of the opioid overdose reversal medication and that students are informed of the training; and,
- Establishes the primary concern of the CCC and CSU is to keep students safe and that disciplinary measures will not be imposed for incidents that result from the use of the overdose reversal medication.
COMMENTS
Naloxone Statewide Standing Order. The Naloxone Statewide Standing Order, allowed 1) community organizations, schools, universities, and a host of other organizations to distribute naloxone (opioid antagonist) to either a person at risk of an opioid-related overdose, or to a family member, friend, or other person in a position to assist the at-risk person; and, 2) allowed the recipient of the naloxone to administer the antagonist to a person experiencing or reasonably suspected of experiencing an opioid overdose.
The Naloxone Statewide Standing Order was established to reduce the number of deaths associated with an opioid overdose through community action. Community organizations could apply for a "permit" to distribute naloxone by agreeing to the terms and conditions set forth by the CDPH. The terms and conditions require the recipient entity of the naloxone to train individuals on how to use the drug and require the entities to report back to the CDPH the number of known reversals that occurred due to the distribution of naloxone. CDPH created a publicly accessible training video that demonstrates how to use the overdose reversal medication and how to properly care for those who received the medication until medical health professional arrive.
The Naloxone Distribution Project. After applying for the standing order, entities were encouraged by CDPH to apply for free naloxone from the California Department of Healthcare Services (CDHS) through the Naloxone Distribution Project. The CDHS created the Naloxone Distribution Project in October 2018 to work in tandem with the Naloxone Statewide Standing Order to combat opioid overdose-related deaths. The funding for the project is received through the State General Funds and from monetary settlements with Janssen and Distributors Settlement Agreements. In the 2023-2024 budget, the State increased budget funding for the project by $74.75 million. Since its inception, the Naloxone Distribution Project has distributed more than 3 million naloxone kits which have saved more than 250,000 lives.
Entities are able to apply for the free naloxone and can receive shipments of up to 2,400 units from CDHS. Data collected by the CDHS shows that as of March 2024, 10,973 applications have been approved for free naloxone. 1,865 of those approved applicants identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 were provided to schools or colleges.
Campus Opioid Safety Act. SB 367 (Hurtado) established the Campus Opioid Safety Act which required CCC and CSU and requested the UC to do the following:
- Provide educational and prevention information provided by the CDPH about opioid overdose and the use and location of naloxone on campuses during campus orientations; and,
- Have the campus health centers apply for a permit to distribute naloxone through the Naloxone Statewide Standing Order and if approved, subsequently apply to Naloxone Distribution Project to provide free naloxone to the campus community.
In response to the Campus Opioid Safety Act, the CDPH created a toolkit for colleges and universities to use to be in compliance with the law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of the naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering the naloxone under Health and Safety Code Section 1799.102.
Each of the CSU and UC campuses have a designated campus health centers. The CSU provides educational materials that include the location of naloxone on campus through various methods including information on the campus website and during orientation. Since 2023, collectively the 23 campuses of the CSU have provided 5,489 doses of naloxone. A search of UC campus websites yielded a confusing result with each campus seemingly having their own distribution plan with some partnering with nonprofit organizations and other offering naloxone through the campus health center.
The CCC does not require students to attend orientation even if one is offered on campus; therefore it is impossible to confirm if CCC students are receiving the educational materials as intended by Senator Hurtado. 92 community colleges have a health center on campus. How naloxone is distributed varies from campus to campus with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others such as Cerritos College have naloxone available at 11 different locations on campus including the Child Development Center, the Pool, and the Learning Resource Center.
According to the Author
As depicted by the author of the measure, "California continues to fight the war against opioids. SB 367 (Hurtado), Chapter 218, Statute of 2022, which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don't happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed."
Arguments in Support
Generation Up, a student-led educational advocacy organization dedicated to amplifying youth voices, heralds the need for AB 1841, because, "one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to opioid overdose. Training residential life staff on Naloxone administration and stocking university-affiliated housing facilities, like dormitories and apartments, with said opioid overdose reversal medication would allow for the administration of life-saving medication in the most timely manner. By providing students with resources, training, and education to harm reduction, campuses can be made safer and lower the risk of overdose-related death."
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Senate Committee on Appropriations:
- The UC estimates General Fund costs of at least $1.6 million each year to comply with the bill's requirements. This estimate assumes one professional staff per campus, peer interns who are typically part-time student workers for student health programs, and administrative costs for various activities, including training, management, and maintenance such as tracking, stocking, and replenishing the required naloxone.
- The CSU anticipates minor and absorbable costs to stock and monitor the naloxone in each required location throughout residential buildings and communicate with students about the availability of the naloxone. The CSU indicates it already receives naloxone from the Naloxone Distribution Project for use in its student health centers free of charge.
- The Chancellor's Office estimates minor costs for community colleges to send the email notice to students, give naloxone obtained from the state's program to residential advisors, and provide training to residential advisors. The Chancellor's Office indicates that the CCC system currently has 14 colleges with housing with a student capacity of 3,248 students, and estimates that 87 residential advisors would need to be trained to administer naloxone. There are numerous training videos provided for free by federal, state and local agencies. The CCC system does not have any college affiliated fraternity or sorority housing.
VOTES:
ASM HIGHER EDUCATION: 11-0-0
YES: Mike Fong, Ta, Arambula, Boerner, Chen, Essayli, Addis, Jackson, Low, Muratsuchi, Quirk-Silva
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Sanchez, Arambula, Bryan, Calderon, Dixon, Mike Fong, Grayson, Haney, Hart, Jim Patterson, Pellerin, Ta, Villapudua
ABS, ABST OR NV: Wendy Carrillo
ASSEMBLY FLOOR: 72-0-8
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Bains, Bauer-Kahan, Bennett, Berman, Calderon, Juan Carrillo, Wendy Carrillo, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Robert Rivas
ABS, ABST OR NV: Arambula, Boerner, Bonta, Bryan, Cervantes, Megan Dahle, Essayli, Mathis
SENATE FLOOR: 40-0-0
YES: Allen, Alvarado-Gil, Archuleta, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Newman, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
UPDATED
VERSION: August 19, 2024
CONSULTANT: Ellen Cesaretti-Monroy / HIGHER ED. / (916) 319-3960 FN: 0004588
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 1841
Author:(Weber)
As Amended Ver:August 19, 2024
Majority vote
SUMMARY
Requires health centers on campus of the California Community College (CCC) and California State University (CSU) to provide two doses of opioid overdose reversal medication to each housing facilities and sorority and fraternity housing on campus and establishes the opioid overdose reversal medication training and notification requirements for students, residential advisors, and house managers on CCC and CSU campuses.
Senate Amendments
- Requires each campus of the CCC and CSU, and requests each campus of the University of California to notify students by email each academic semester or term the location of fentanyl test strips and opioid overdose reversal medication on campus;
- Establishes a new code section on the provision and training for the use opioid overdose reversal medication to read as follows:
- Requires the CCC and CSU to send an email at the beginning of each semester or term to students informing them that each residential advisor and house manager has received opioid overdose reversal prevention and treatment training;
- Requires the CCC and CSU to train all students who live on campus on how to use the opioid overdose reversal medication during student orientation;
- Requires the campus health centers to provide two doses of opioid overdose reversal medication to each student housing facility and fraternity or sorority facility;
- Requires the student housing facility and the fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an assessable location and that each residential advisor or house manager is aware of the location of the medication;
- Requires that each residential advisor and each house manager receive training on the use of the opioid overdose reversal medication and that students are informed of the training; and,
- Establishes the primary concern of the CCC and CSU is to keep students safe and that disciplinary measures will not be imposed for incidents that result from the use of the overdose reversal medication.
COMMENTS
Naloxone Statewide Standing Order. The Naloxone Statewide Standing Order, allowed 1) community organizations, schools, universities, and a host of other organizations to distribute naloxone (opioid antagonist) to either a person at risk of an opioid-related overdose, or to a family member, friend, or other person in a position to assist the at-risk person; and, 2) allowed the recipient of the naloxone to administer the antagonist to a person experiencing or reasonably suspected of experiencing an opioid overdose.
The Naloxone Statewide Standing Order was established to reduce the number of deaths associated with an opioid overdose through community action. Community organizations could apply for a "permit" to distribute naloxone by agreeing to the terms and conditions set forth by the CDPH. The terms and conditions require the recipient entity of the naloxone to train individuals on how to use the drug and require the entities to report back to the CDPH the number of known reversals that occurred due to the distribution of naloxone. CDPH created a publicly accessible training video that demonstrates how to use the overdose reversal medication and how to properly care for those who received the medication until medical health professional arrive.
The Naloxone Distribution Project. After applying for the standing order, entities were encouraged by CDPH to apply for free naloxone from the California Department of Healthcare Services (CDHS) through the Naloxone Distribution Project. The CDHS created the Naloxone Distribution Project in October 2018 to work in tandem with the Naloxone Statewide Standing Order to combat opioid overdose-related deaths. The funding for the project is received through the State General Funds and from monetary settlements with Janssen and Distributors Settlement Agreements. In the 2023-2024 budget, the State increased budget funding for the project by $74.75 million. Since its inception, the Naloxone Distribution Project has distributed more than 3 million naloxone kits which have saved more than 250,000 lives.
Entities are able to apply for the free naloxone and can receive shipments of up to 2,400 units from CDHS. Data collected by the CDHS shows that as of March 2024, 10,973 applications have been approved for free naloxone. 1,865 of those approved applicants identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 were provided to schools or colleges.
Campus Opioid Safety Act. SB 367 (Hurtado) established the Campus Opioid Safety Act which required CCC and CSU and requested the UC to do the following:
- Provide educational and prevention information provided by the CDPH about opioid overdose and the use and location of naloxone on campuses during campus orientations; and,
- Have the campus health centers apply for a permit to distribute naloxone through the Naloxone Statewide Standing Order and if approved, subsequently apply to Naloxone Distribution Project to provide free naloxone to the campus community.
In response to the Campus Opioid Safety Act, the CDPH created a toolkit for colleges and universities to use to be in compliance with the law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of the naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering the naloxone under Health and Safety Code Section 1799.102.
Each of the CSU and UC campuses have a designated campus health centers. The CSU provides educational materials that include the location of naloxone on campus through various methods including information on the campus website and during orientation. Since 2023, collectively the 23 campuses of the CSU have provided 5,489 doses of naloxone. A search of UC campus websites yielded a confusing result with each campus seemingly having their own distribution plan with some partnering with nonprofit organizations and other offering naloxone through the campus health center.
The CCC does not require students to attend orientation even if one is offered on campus; therefore it is impossible to confirm if CCC students are receiving the educational materials as intended by Senator Hurtado. 92 community colleges have a health center on campus. How naloxone is distributed varies from campus to campus with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others such as Cerritos College have naloxone available at 11 different locations on campus including the Child Development Center, the Pool, and the Learning Resource Center.
According to the Author
As depicted by the author of the measure, "California continues to fight the war against opioids. SB 367 (Hurtado), Chapter 218, Statute of 2022, which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don't happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed."
Arguments in Support
Generation Up, a student-led educational advocacy organization dedicated to amplifying youth voices, heralds the need for AB 1841, because, "one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to opioid overdose. Training residential life staff on Naloxone administration and stocking university-affiliated housing facilities, like dormitories and apartments, with said opioid overdose reversal medication would allow for the administration of life-saving medication in the most timely manner. By providing students with resources, training, and education to harm reduction, campuses can be made safer and lower the risk of overdose-related death."
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Senate Committee on Appropriations:
- The UC estimates General Fund costs of at least $1.6 million each year to comply with the bill's requirements. This estimate assumes one professional staff per campus, peer interns who are typically part-time student workers for student health programs, and administrative costs for various activities, including training, management, and maintenance such as tracking, stocking, and replenishing the required naloxone.
- The CSU anticipates minor and absorbable costs to stock and monitor the naloxone in each required location throughout residential buildings and communicate with students about the availability of the naloxone. The CSU indicates it already receives naloxone from the Naloxone Distribution Project for use in its student health centers free of charge.
- The Chancellor's Office estimates minor costs for community colleges to send the email notice to students, give naloxone obtained from the state's program to residential advisors, and provide training to residential advisors. The Chancellor's Office indicates that the CCC system currently has 14 colleges with housing with a student capacity of 3,248 students, and estimates that 87 residential advisors would need to be trained to administer naloxone. There are numerous training videos provided for free by federal, state and local agencies. The CCC system does not have any college affiliated fraternity or sorority housing.
VOTES:
ASM HIGHER EDUCATION: 11-0-0
YES: Mike Fong, Ta, Arambula, Boerner, Chen, Essayli, Addis, Jackson, Low, Muratsuchi, Quirk-Silva
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Sanchez, Arambula, Bryan, Calderon, Dixon, Mike Fong, Grayson, Haney, Hart, Jim Patterson, Pellerin, Ta, Villapudua
ABS, ABST OR NV: Wendy Carrillo
ASSEMBLY FLOOR: 72-0-8
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Bains, Bauer-Kahan, Bennett, Berman, Calderon, Juan Carrillo, Wendy Carrillo, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Robert Rivas
ABS, ABST OR NV: Arambula, Boerner, Bonta, Bryan, Cervantes, Megan Dahle, Essayli, Mathis
UPDATED
VERSION: August 19, 2024
CONSULTANT: Ellen Cesaretti-Monroy / HIGHER ED. / (916) 319-3960 FN: 0004588
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 1841 |
THIRD READING
Bill No: AB 1841
Author: Weber (D)
Amended: 8/19/24 in Senate
Vote: 21
SENATE EDUCATION COMMITTEE: 7-0, 5/29/24
AYES: Newman, Ochoa Bogh, Cortese, Glazer, Gonzalez, Smallwood-Cuevas, Wilk
SENATE HEALTH COMMITTEE: 11-0, 6/19/24
AYES: Roth, Nguyen, Glazer, Gonzalez, Grove, Hurtado, Limón, Menjivar, Rubio, Smallwood-Cuevas, Wiener
SENATE APPROPRIATIONS COMMITTEE: 6-0, 8/15/24
AYES: Caballero, Jones, Ashby, Becker, Seyarto, Wahab
NO VOTE RECORDED: Bradford
ASSEMBLY FLOOR: 72-0, 4/18/24 (Consent) - See last page for vote
SUBJECT: Student safety: opioid overdose reversal medication: student housing facilities
SOURCE: Generation Up
DIGEST:
This bill requires that the California Community Colleges (CCCs) and the California State University (CSU) make federally approved opioid overdose reversal medication available on campuses and in affiliated housing and to train specified individuals in a position to quickly respond in emergencies.
Senate Floor Amendments of 8/19/24 remove the University of California from the bill and recast its provisions.
ANALYSIS:
Existing law:
1) Requires the governing board of each CCC district and the Trustees of the CSU, and requests the Regents of the University of California (UC) to do the following:
- Collaborate with campus-based and community-based recovery advocacy organization to provide educational and prevention information provided by the California Department of Public Health (CDPH) about opioid overdose during the campus orientation. The educational and prevention materials should include information about the location of fentanyl test strips and opioid overdose reversal medication on campus.
- Notify students of the presence and location of fentanyl test strips via email.
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project.
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the California Department of Health Care Services (CDHS).
iii) Stock and distribute fentanyl strips with written instruction on how to properly use the fentanyl test strips. (Education Code § 67384)
This bill:
- Requires the governing board of each community college district and the CSU Trustees to:
- Notify students, by sending an email at the beginning of each academic semester or term, that each residential advisor and house manager, or the equivalent position, has received opioid overdose prevention and treatment training consistent with Naloxone Distribution Project terms and conditions.
- Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
- Require that each campus health center located on a campus within their respective segments distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with tits terms and conditions, to each university-or college-affiliated student housing facility and each university-or college-affiliated fraternity or sorority facility.
- Require each university- or college-affiliated student housing facility to maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the lockable, emergency-breakable boxes.
- Require each university- or college-affiliated fraternity or sorority facility to maintain unexpired doses of the opioid overdose reversal medication in an accessible location and ensure that each house manager, or the equivalent position, is aware of the location of the opioid overdose reversal medication.
- Ensure that each residential advisor and each house manager receive opioid overdose prevention and treatment training consistent with the Naloxone Distribution Project’s terms and conditions.
g) Include in the training at the beginning of each academic semester that each residential advisor and house manager inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
- States that the institution’s primary concern in implementing the bill’s provisions be student safety and prohibits disciplinary measures from being imposed for any violation of the institution’s student conduct policy regarding drug possession, use, or treatment that occurs near the time of an incident where the residential advisor or house manager administers a dose of opioid overdose reversal medication obtained through the Naloxone Distribution Project.
Comments
- Need for the bill. According to the author, “There has been an increase in opioid-related deaths in California, with reported opioid deaths skyrocketing to 6800 in 2021. Specifically one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to fentanyl overdose.” The author further states, “California continues to fight the war against opioids. SB 367 which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don’t happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed.”
- Naloxone. According to information posted on the CDPH website, Naloxone, a prescription drug, is an opioid antagonist that works almost immediately to reverse an opiate overdose. It further states that Naloxone has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders such as friends, family, and other non-health-care providers, as well as drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose.
- Statewide Standing Order for Naloxone Distribution. Current law, established by SB 367 (Hurtado, Chapter 218, Statutes of 2022), calls for each health center located on a UC, CSU, or CCC campus to apply for the statewide standing order issued by CDPH and participate in the Naloxone Distribution Project. If approved, health centers are to distribute the medication according to the project’s terms and conditions. The statewide standing order issued by CDPH allows organizations and entities, including colleges and universities, to distribute naloxone to a person at-risk of experiencing an overdose or an individual in a position to assist a person at-risk. Staff of community organizations and other entities distributing naloxone under the statewide standing order are required to receive training and are also required to train individuals who receive naloxone from them. Organizations, including colleges, may apply to use the statewide standing order and meet certain terms and conditions. A separate distribution program administered through the CDHS allows universities and colleges to apply for and obtain Naloxone at no cost to the institution. As of March 2024, the data collected by the CDHS shows that 10,973 applications were approved for free naloxone. 1,865 of the approved applicants were identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 went to schools or colleges.
- Focus on student safety. This bill attempts to ensure that students who are living in college-affiliated housing facilities including sorority or fraternity housing have access to overdose reversal medication on site. The Naloxone Distribution Project’s terms and conditions would still apply. Residential advisors and house managers must maintain unexpired doses of the medication in accessible locations. The bill emphasizes student safety and prohibits disciplinary measures from being taken for any violation of the institution’s student conduct policy related drug possession, use, or treatment that occurs near the time of an incident where the residential advisor or house manager administers the medication obtained through the Naloxone Distribution Project. As mentioned, under the Naloxone Distribution Project, entities distributing naloxone are required to train individuals who receive naloxone from them on opioid overdose prevention and treatment. Recipient entities are required to report to CDPH the number of known reversals that occurred due to naloxone distribution. Under this bill, campus health centers must ensure that residential advisors and housing managers receive the training and further specifies that each campus conduct training for all students living on campus.
- Status on implementation. CDPH created a toolkit for colleges and universities to use to be in compliance with existing law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use Narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering naloxone under Health and Safety Code Section 1799.102.
Each of the CSU and 92 CCC campuses has a designated campus health center. The CSU provides educational materials that include the location of naloxone on campus through various methods, including information on the campus website and during orientation. Since 2023, collectively, the 23 campuses of the CSU have provided 5,489 doses of naloxone. Within the CCC system, how naloxone is distributed varies from campus to campus, with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others, such as Cerritos College, have naloxone available at 11 different locations on campus, including the Child Development Center, the Pool, and the Learning Resource Center.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee,
- The UC estimates General Fund costs of at least $1.6 million each year to comply with the bill’s requirements. This estimate assumes one professional staff per campus, peer interns who are typically part-time student workers for student health programs, and administrative costs for various activities, including training, management, and maintenance such as tracking, stocking, and replenishing the required naloxone.
- The CSU anticipates minor and absorbable costs to stock and monitor the naloxone in each required location throughout residential buildings and communicate with students about the availability of the naloxone. The CSU indicates it already receives naloxone from the Naloxone Distribution Project for use in its student health centers free of charge.
- The Chancellor’s Office estimates minor costs for community colleges to send the email notice to students, give naloxone obtained from the state’s program to residential advisors, and provide training to residential advisors. The Chancellor’s Office indicates that the CCC system currently has 14 colleges with housing with a student capacity of 3,248 students, and estimates that 87 residential advisors would need to be trained to administer naloxone. There are numerous training videos provided for free by federal, state and local agencies. The CCC system does not have any college affiliated fraternity or sorority housing.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
SUPPORT: (Verified 8/20/24)
Generation Up (source)
California Academy of Family Physicians
California Alliance of Child and Family Services
California Association of Alcohol and Drug Program Executives
California Chiropractic Association
California District Attorneys Association
California Federation of Teachers
California Society of Health System Pharmacists
California Teachers Association
Faculty Association of California Community Colleges
Indivisible CA: StateStrong
Solano County Democratic Central Committee
OPPOSITION: (Verified 8/20/24)
None received
ASSEMBLY FLOOR: 72-0, 4/18/24
AYES: Addis, Aguiar-Curry, Alanis, Alvarez, Bains, Bauer-Kahan, Bennett, Berman, Calderon, Juan Carrillo, Wendy Carrillo, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Robert Rivas
NO VOTE RECORDED: Arambula, Boerner, Bonta, Bryan, Cervantes, Megan Dahle, Essayli, Mathis
Prepared by: Olgalilia Ramirez / ED. / (916) 651-4105
8/20/24 16:01:42
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 1841 |
THIRD READING
Bill No: AB 1841
Author: Weber (D)
Amended: 6/10/24 in Senate
Vote: 21
SENATE EDUCATION COMMITTEE: 7-0, 5/29/24
AYES: Newman, Ochoa Bogh, Cortese, Glazer, Gonzalez, Smallwood-Cuevas, Wilk
SENATE HEALTH COMMITTEE: 11-0, 6/19/24
AYES: Roth, Nguyen, Glazer, Gonzalez, Grove, Hurtado, Limón, Menjivar, Rubio, Smallwood-Cuevas, Wiener
SENATE APPROPRIATIONS COMMITTEE: 6-0, 8/15/24
AYES: Caballero, Jones, Ashby, Becker, Seyarto, Wahab
NO VOTE RECORDED: Bradford
ASSEMBLY FLOOR: 72-0, 4/18/24 (Consent) - See last page for vote
SUBJECT: Student safety: opioid overdose reversal medication: student housing facilities
SOURCE: Generation Up
DIGEST:
This bill requires the California Community Colleges (CCCs) and the California State University (CSU), and requests the University of California (UC), to make federally approved opioid overdose reversal medication available on campuses and in affiliated housing and to train specified individuals in a position to quickly respond in emergencies.
ANALYSIS:
Existing law:
1) Requires the governing board of each CCC district and the Trustees of the CSU, and requests the Regents of the UC to do the following:
- Collaborate with campus-based and community-based recovery advocacy organization to provide educational and prevention information provided by the State Department of Public Health (CDPH) about opioid overdose during the campus orientation. The educational and prevention materials should include information about the location of fentanyl test strips and opioid overdose reversal medication on campus.
- Notify students of the presence and location of fentanyl test strips via email.
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project.
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the State Department of Health Care Services (CDHS).
iii) Stock and distribute fentanyl strips with written instruction on how to properly use the fentanyl test strips. (Education Code § 67384)
This bill:
- Requires the governing board of each community college district and the CSU Trustees and requests the UC Regents to:
- Notify students by email at the beginning of each academic semester or term of the presence and location of fentanyl test strips and opioid overdose reversal medication, and that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication.
- Train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
- Requires health centers on CCC and CSU campuses and requests health centers on UC campuses to do all of the following:
- Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions:
- To each university- or college-affiliated student housing facility and each university- or college-affiliated fraternity or sorority facility. Each university- or college-affiliated student housing facility is required to maintain unexpired doses of the opioid overdose reversal medication in two different accessible locations in a lockable, emergency-breakable box and ensure that each residential advisor, or the equivalent position, and each resident are aware of its locations. Each university- or college affiliate fraternity or sorority facility is require to maintain unexpired doses of the medication in an accessible location and ensure that each house manager, or the equivalent position, is award of its location.
- Ensure that each residential advisor and each house manager receive opioid overdose prevention and treatment training consistent with the Naloxone Distribution Project’s terms and conditions.
- Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions:
c) Include in the training at the beginning of each academic semester that each residential advisor and house manager inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
- States that the institution’s primary concern in implementing the bill’s provisions be student safety and prohibits disciplinary measures from being imposed for any violation of the institution’s student conduct policy regarding drug possession, use, or treatment that occurs near the time of an incident where the residential advisor or house manager administers a dose of opioid overdose reversal medication obtained through the Naloxone Distribution Project.
Comments
- Need for the bill. According to the author, “There has been an increase in opioid-related deaths in California, with reported opioid deaths skyrocketing to 6800 in 2021. Specifically one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to fentanyl overdose.” The author further states, “California continues to fight the war against opioids. SB 367 which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don’t happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed.”
- Naloxone. According to information posted on the CDPH website, Naloxone, a prescription drug, is an opioid antagonist that works almost immediately to reverse an opiate overdose. It further states that Naloxone has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders such as friends, family, and other non-health-care providers, as well as drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose.
- Statewide Standing Order for Naloxone Distribution. Current law, established by SB 367 (Hurtado, Chapter 218, Statutes of 2022), calls for each health center located on a UC, CSU, or CCC campus to apply for the statewide standing order issued by CDPH and participate in the naloxone distribution project. If approved, health centers are to distribute the medication according to the project’s terms and conditions. The statewide standing order issued by CDPH allows organizations and entities, including colleges and universities, to distribute naloxone to a person at-risk of experiencing an overdose or an individual in a position to assist a person at-risk. Staff of community organizations and other entities distributing naloxone under the statewide standing order are required to receive training and are also required to train individuals who receive naloxone from them. Organizations, including colleges, may apply to use the statewide standing order and meet certain terms and conditions. A separate distribution program administered through the CDHS allows universities and colleges to apply for and obtain Naloxone at no cost to the institution. As of March 2024, the data collected by the CDHS shows that 10,973 applications were approved for free naloxone. 1,865 of the approved applicants were identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 went to schools or colleges.
- Focus on student safety. This bill attempts to ensure that students who are living in college-affiliated housing facilities including sorority or fraternity housing have access to overdose reversal medication on site. The Naloxone Distribution Project’s terms and conditions would still apply. Residential advisors and house managers must maintain unexpired doses of the medication in accessible locations. The bill emphasizes student safety and prohibits disciplinary measures from being taken for any violation of the institution’s student conduct policy related drug possession, use, or treatment that occurs near the time of an incident where the residential advisor or house manager administers the medication obtained through the Naloxone Distribution Project. As mentioned, under the Naloxone Distribution Project, entities distributing naloxone are required to train individuals who receive naloxone from them on opioid overdose prevention and treatment. Recipient entities are required to report to CDPH the number of known reversals that occurred due to naloxone distribution. Under this bill, campus health centers must ensure that residential advisors and housing managers receive the training and further specifies that each campus conduct training for all students living on campus.
- Status on implementation. CDPH created a toolkit for colleges and universities to use to be in compliance with existing law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use Narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering naloxone under Health and Safety Code Section 1799.102.
Each of the CSU, UC, and 92 CCC campuses has a designated campus health center. The CSU provides educational materials that include the location of naloxone on campus through various methods, including information on the campus website and during orientation. Since 2023, collectively, the 23 campuses of the CSU have provided 5,489 doses of naloxone. Within the CCC system, how naloxone is distributed varies from campus to campus, with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others, such as Cerritos College, have naloxone available at 11 different locations on campus, including the Child Development Center, the Pool, and the Learning Resource Center.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee,
- The UC estimates General Fund costs of at least $1.6 million each year to comply with the bill’s requirements. This estimate assumes one professional staff per campus, peer interns who are typically part-time student workers for student health programs, and administrative costs for various activities, including training, management, and maintenance such as tracking, stocking, and replenishing the required naloxone.
- The CSU anticipates minor and absorbable costs to stock and monitor the naloxone in each required location throughout residential buildings and communicate with students about the availability of the naloxone. The CSU indicates it already receives naloxone from the Naloxone Distribution Project for use in its student health centers free of charge.
- The Chancellor’s Office estimates minor costs for community colleges to send the email notice to students, give naloxone obtained from the state’s program to residential advisors, and provide training to residential advisors. The Chancellor’s Office indicates that the CCC system currently has 14 colleges with housing with a student capacity of 3,248 students, and estimates that 87 residential advisors would need to be trained to administer naloxone. There are numerous training videos provided for free by federal, state and local agencies. The CCC system does not have any college affiliated fraternity or sorority housing.
SUPPORT: (Verified 8/15/24)
Generation Up (source)
California Academy of Family Physicians
California Alliance of Child and Family Services
California Association of Alcohol and Drug Program Executives
California Chiropractic Association
California District Attorneys Association
California Federation of Teachers
California Society of Health System Pharmacists
California Teachers Association
Faculty Association of California Community Colleges
Indivisible CA: StateStrong
Solano County Democratic Central Committee
OPPOSITION: (Verified 8/14/24)
None received
ASSEMBLY FLOOR: 72-0, 4/18/24
AYES: Addis, Aguiar-Curry, Alanis, Alvarez, Bains, Bauer-Kahan, Bennett, Berman, Calderon, Juan Carrillo, Wendy Carrillo, Chen, Connolly, Davies, Dixon, Flora, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Rendon, Reyes, Luz Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Wallis, Ward, Weber, Wicks, Wilson, Wood, Zbur, Robert Rivas
NO VOTE RECORDED: Arambula, Boerner, Bonta, Bryan, Cervantes, Megan Dahle, Essayli, Mathis
Prepared by: Olgalilia Ramirez / ED. / (916) 651-4105
8/18/24 8:51:00
**** END ****
SENATE COMMITTEE ON
Senator Anna Caballero, Chair
2023 - 2024 Regular Session
AB 1841 (Weber) - Student safety: opioid overdose reversal medication: student housing facilities
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
This bill requires the California Community Colleges (CCCs) and the California State University (CSU), and requests the University of California (UC), to make federally approved opioid overdose reversal medication available on campuses and in affiliated housing and to train specified individuals in a position to quickly respond in emergencies.
Fiscal Impact:
- The UC estimates General Fund costs of at least $1.6 million each year to comply with the bill’s requirements. This estimate assumes one professional staff per campus, peer interns who are typically part-time student workers for student health programs, and administrative costs for various activities, including training, management, and maintenance such as tracking, stocking, and replenishing the required naloxone.
- The CSU anticipates minor and absorbable costs to stock and monitor the naloxone in each required location throughout residential buildings and communicate with students about the availability of the naloxone. The CSU indicates it already receives naloxone from the Naloxone Distribution Project for use in its student health centers free of charge.
- The Chancellor’s Office estimates minor costs for community colleges to send the email notice to students, give naloxone obtained from the state’s program to residential advisors, and provide training to residential advisors. The Chancellor’s Office indicates that the CCC system currently has 14 colleges with housing with a student capacity of 3,248 students, and estimates that 87 residential advisors would need to be trained to administer naloxone. There are numerous training videos provided for free by federal, state and local agencies. The CCC system does not have any college affiliated fraternity or sorority housing.
Background:
Existing law requires the governing board of each community college district (CCD) and the Trustees of the CSU, and requests the Regents of the UC to do the following:
- In collaboration with campus-based and community-based recovery advocacy organizations, provide educational and prevention information provided by CDPH about opioid overdose and about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses;
- Notify students of the presence and location of fentanyl test strips via email; and,
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project (NDP);
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the Department of Health Care Services (DHCS); and,
- Stock and distribute fentanyl strips with written instructions on how to properly use them.
Proposed Law:
This bill requires CCDs and the CSU, and requests UC, to notify students at the beginning of each academic semester or term, through email, that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication. The bill requires that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term.
This bill requires CCDs and the CSU, and requests UC, to distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the NDP to each university- or college-affiliated student housing facility, fraternity facility, and sorority facility. The bill also requires these housing facilities to maintain unexpired doses in two different accessible locations in a lockable, emergency-breakable box, and to ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the boxes. It prohibits disciplinary measures from being imposed for any violation of each institution’s student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential advisor, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the NDP.
This bill would ensure that each residential advisor and each house manager, or the equivalent positions, receive opioid overdose prevention and treatment training consistent with the NDP, and require the training to include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, are required to inform students they have been trained to use opioid overdose reversal medication and have access to it in the event of an overdose.
Related Legislation:
AB 461 (Ramos, Chapter 525, Statutes of 2023) requires CCDs and the CSU, and requests UC, to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center.
SB 367 (Hurtado, Chapter 218, Statutes of 2022) requires CCDs and the CSU, and requests UC, to distribute a federally approved opioid overdose reversal medication to students and to provide educational and preventive information about opioid overdose and reversal medication, as specified.
Staff Comments:
Naloxone is a prescription drug and an opioid antagonist that works almost immediately to reverse an opiate overdose. Naloxone has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders such as friends, family, and other non-health-care providers, as well as drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose.
According to the author, “California continues to fight the war against opioids. SB 367 (Hurtado, Chapter 218, Statues of 2022) required college campus health centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. This bill would require residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medications as well. Opioid overdoses do not happen at the health center; they are more likely to occur where the students spend the majority of their free time. This bill would save lives by placing the opioid overdose reversal medication where it is needed.”
-- END --
SENATE COMMITTEE ON HEALTH
Senator Richard Roth, Chair
BILL NO: AB 1841
AUTHOR: | Weber | ||
VERSION: | June 10, 2024 | ||
HEARING DATE: | June 19, 2024 | ||
CONSULTANT: | Reyes Diaz | ||
SUBJECT: Student safety: opioid overdose reversal medication: student housing facilities
SUMMARY:
Requires each community college district and the Trustees of the California State University, and requests the Regents of the University of California, to make federally approved opioid overdose reversal medication available throughout specified locations on campuses and in affiliated housing and to train specified individuals in a position to quickly respond in emergencies.
Existing law:
- Establishes the California Department of Public Health (CDPH) to be vested with all the duties, powers, purposes, functions, responsibilities, and jurisdiction as they relate to public health, as specified. [HSC §131050]
- Establishes the Department of Health Care Services (DHCS) as the sole authority for all substance use disorder (SUD) functions and programs in the state. [HSC §11750 et seq.]
- Requires the governing board of each community college district (CCD) and the Trustees of the California State University (CSU), and requests the Regents of the University of California (UC) to do the following:
- In collaboration with campus-based and community-based recovery advocacy organizations, provide educational and prevention information provided by CDPH about opioid overdose and about the use and location of fentanyl test strips and opioid overdose reversal medication to students at all campuses;
- Notify students of the presence and location of fentanyl test strips via email; and,
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project (NDP);
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the Department of Health Care Services (DHCS); and,
- Stock and distribute fentanyl strips with written instructions on how to properly use them. [EDC §67384]
This bill: Requires CCD and CSU, and requests UC, to:
- Notify students at the beginning of each academic semester or term, through email, that each residential advisor, or the equivalent position, has been trained on the use of opioid overdose reversal medication;
- Require that each campus train all students who live on campus on the use of opioid overdose reversal medication during student orientation for each academic semester or term;
- Distribute, at the beginning of each academic semester or term, two doses of a federally approved opioid overdose reversal medication obtained through the NDP to each university- or college-affiliated student housing facility, fraternity facility, and sorority facility. Requires these housing facilities to maintain unexpired doses in two different accessible locations in a lockable, emergency-breakable box, and to ensure that each residential advisor, or the equivalent position, and each resident are aware of the locations of the boxes. Prohibit disciplinary measures from being imposed for any violation of each institution’s student conduct policy regarding drug possession, use, or treatment that occurs at or near the time of an incident where the residential advisor, or the equivalent position, or resident administers a dose of a federally approved opioid overdose reversal medication obtained through the NDP; and,
- Ensure that each residential advisor and each house manager, or the equivalent positions, receive opioid overdose prevention and treatment training consistent with the NDP. Require the training to include instruction that, at the beginning of each academic semester or term, each residential advisor and house manager, or the equivalent positions, are required to inform students they have been trained to use opioid overdose reversal medication and have access to it in the event of an overdose.
FISCAL EFFECT:
According to the Assembly Appropriations Committee:
- Minor and absorbable ongoing General Fund costs to CSUs and UCs to procure the naloxone through the NDP, provide it to the appropriate points of contact, and periodically notify students of the naloxone’s location.
- Minor and absorbable ongoing Proposition 98 General Fund costs to Community Colleges (CCs) to procure the naloxone through the NDP, provide it to the appropriate points of contact, and periodically notify students of the naloxone’s location.
- The state would need to reimburse these costs to CCs, if the Commission on State Mandates determines the bill’s requirements to be a reimbursable state mandate.
- Minor and absorbable ongoing General Fund costs to CDPH.
PRIOR VOTES:
Senate Education Committee: | 7 - 0 |
Assembly Floor: | 72 - 0 |
Assembly Appropriations Committee: | 14 - 0 |
Assembly Higher Education Committee: | 11 - 0 |
COMMENTS:
- Author’s statement. According to the author, California continues to fight the war against opioids. SB 367 (Hurtado, Chapter 218, Statues of 2022) required college campus health centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. This bill would require residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medications as well. Opioid overdoses do not happen at the health center; they are more likely to occur where the students spend the majority of their free time. This bill would save lives by placing the opioid overdose reversal medication where it is needed.
- Naloxone. According to the CDPH website, naloxone, a prescription drug, is an opioid antagonist that works almost immediately to reverse opiate overdose and has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders, such as friends, family, and other non-health care providers, and drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose.
- Statewide standing order for naloxone distribution. CDPH issued a statewide standing order for naloxone in June 2018. The order allows organizations and entities, including k-12 schools, colleges, and universities, to distribute naloxone to a person who is at risk of experiencing an overdose or an individual in a position to assist an at-risk person. Staff of community organizations and other entities distributing naloxone under the statewide standing order are required to receive training, and are also required to provide training to individuals who receive naloxone from them. Organizations may apply to use the statewide standing order and meet certain terms and conditions. A separate distribution program administered through DHCS allows various entities to apply for and obtain naloxone at no cost.
- NDP. The NDP aims to reduce opioid overdose deaths through the provision of free naloxone. Entities can apply to DHCS to have naloxone shipped directly to their address. Eligible entities include:
- Community organizations;
- County health agencies;
- Community clinics or federally qualified health centers;
- Emergency departments or hospitals;
- Emergency medical services;
- Fire authorities;
- First responders;
- Law enforcement, courts, and criminal justice partners;
- Libraries;
- Local city agencies;
- Organizations that provide services to unhoused individuals/community;
- Religious organizations;
- Schools and universities;
- Substance use recovery facilities;
- Veteran organizations; and,
- Tribal entities.
Since it began in October 2018, the NDP has distributed more than 4,290,900 kits of naloxone, which have been used to reverse more than 273,000 overdoses. The NDP receives State General Funds and opioid settlement funds from the Janssen and Distributors (J&D) Settlement Agreements.
- Governor’s Master Plan for Tackling Fentanyl and the Opioid Crisis. In March 2023, the Governor unveiled California’s master plan for tackling the fentanyl and opioid crisis. The master plan includes allocations and activities in the following areas:
- $79 million for enhancement of the NDP administered by DHCS;
- $10 million in grants for education, testing, recovery, and support services;
- $4 million to make fentanyl test strips more available;
- $3.5 million to provide overdose medications (naloxone/Narcan) to all middle and high schools;
- $30 million to expand California National Guard’s (Cal Guard) work to prevent drug trafficking through the hiring, training and embedding of 144 new members (in 2022, 28,765 pounds of fentanyl were seized in operations supported by Cal Guard, an increase of 594% in seizures since 2021);
- $15 million over two years to establish and operate the Fentanyl Enforcement Program with the California Department of Justice to combat manufacturing, distribution, and trafficking;
- $40.8 million for an education and awareness campaign to establish partnerships and create messaging and education tools for parents and educators;
- $23 million to develop SUD training for non-behavioral health professionals working with children and youth; and,
- Manufacture naloxone for California through CalRx. Effective May 6, 2024, those applying through the NDP will either receive the generic 4mg naloxone nasal spray labeled either as “CalRx” or “Amneal,” which is manufactured by Amneal Pharmaceuticals through the CalRx Naloxone Access Initiative, or Narcan nasal spray manufactured by Emergent BioSolutions.
- Double referral. This bill was heard in the Senate Education Committee on May 29, 2024, and passed with a 7-0 vote.
- Prior legislation. AB 461 (Ramos, Chapter 525, Statutes of 2023) updated SB 367 (Hurtado) to, among other things, require CCD and CSU, and request UC, to stock fentanyl test strips in the campus health center and distribute the test strips through the campus health center.
SB 367 (Hurtado, Chapter 218, Statues of 2022) implemented current law requiring CCD and CSU, and requesting UC, to utilize a statewide standing order through CDPH to distribute a federally approved opioid overdose reversal medication to students and to provide educational and preventive information about opioid overdose and reversal medication, as specified.
- Support. The Sponsor, Generation Up, states that opioid overdose and death have been an increasing problem in both college campuses and the United States as a whole. California is facing an opioid crisis considering opioid deaths have skyrocketed to 6,800 in 2021. Specifically, one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to opioid overdose. Training residential life staff on naloxone administration and stocking university-affiliated housing facilities, like dormitories and apartments, with said opioid overdose reversal medication would allow for the administration of life-saving medication in the most timely manner. By providing students with resources, training, and education of harm reduction, campuses can be made safer and lower the risk of overdose-related deaths.
The California Alliance of Child and Family Services states that faculty across California have experienced firsthand the heartbreak of losing bright, talented students to accidental overdoses. We have a responsibility to implement sensible harm reduction policies that reflect the realities that students face. Keeping nasal naloxone on hand and staff trained in dormitories is equivalent to having defibrillators and resident advisors trained in CPR. This legislation complements existing campus efforts to promote education and awareness about substance use.
SUPPORT AND OPPOSITION:
Support: Generation Up (sponsor)
California Alliance of Child and Family Services
California Association of Alcohol and Drug Program Executives
California Chiropractic Association
California District Attorneys Association
California Federation of Teachers
California Society of Health System Pharmacists
California Teachers Association
Faculty Association of California Community Colleges
Indivisible CA: StateStrong
Solano County Democratic Central Committee
Oppose: None received
-- END --
SENATE COMMITTEE ON EDUCATION
Senator Josh Newman, Chair
2023 - 2024 Regular
Bill No: Hearing Date: May 29, 2024
Author: | Weber | ||
Version: |
| ||
Urgency: | Fiscal: | ||
Consultant: | |||
Subject:
NOTE: This bill has been referred to the Committees on Education and Health. A "do pass" motion should include referral to the Committee on Health.
SUMMARY
This bill requires health centers on California Community College (CCC) campuses and California State University (CSU) campuses, and requests health centers on University of California (UC) campuses, to provide two doses of opioid overdose reversal medication, as specified, to each campus residential advisor and each house manager of sorority and fraternity housing and ensure that they receive treatment training. It further requires the governing board of each CCC district and the CSU Trustees, and requests the Regents of the UC to notify students as prescribed regarding the location of fentanyl test strips and opioid overdose reversal medication. Lastly, the bill would prohibit disciplinary measures from being imposed for drug related violations of the institution’s student conduct policy when a dose is administered.
BACKGROUND
Existing law:
1) Requires the governing board of each CCC district and the Trustees of the CSU, and requests the Regents of the UC to do the following:
- Collaborate with campus-based and community-based recovery advocacy organization to provide educational and prevention information provided by the State Department of Public Health (CDPH) about opioid overdose during the campus orientation. The educational and prevention materials should include information about the location of fentanyl test strips and opioid overdose reversal medication on campus.
- Notify students of the presence and location of fentanyl test strips via email.
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project.
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the State Department of Health Care Services (CDHS).
iii) Stock and distribute fentanyl strips with written instruction’s on how to properly use the fentanyl test strips. (Education Code § 67384)
ANALYSIS
This bill:
- Requires health centers on CCC and CSU campuses and requests health centers on UC campuses to do all of the following:
- Distribute, at the beginning of each academic semester or term, two doses
of a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions:
- To each residential advisor in college housing facilities and each
house manager of a college-affiliated sorority and fraternity housing facility, to have either in their room or on-their-person while on-call.
- Four additional doses, located at each residential housing office
front desk, for a residential advisor to resupply as needed.
- Ensure that each residential advisor and each house manager receive
opioid overdose prevention and treatment training consistent with the Naloxone Distribution Project’s terms and conditions.
c) Include in the training at the beginning of each academic semester that each residential advisor and house manager inform students that they have training to use opioid overdose reversal medication and access to it in the event of an overdose.
- States that the bill does not require a residential advisor or house manager to administer opioid overdose reversal medication. If administered, the bill prohibits disciplinary measures from being imposed for any violation of the institution’s student conduct policy regarding drug possession, use, or treatment that occurs near the time of an incident where the residential advisor or house manager administers a dose of opioid overdose reversal medication obtained through the Naloxone Distribution Project.
- States that the institution’s primary concern in implementing the bill’s provisions be student safety.
- Requires the governing board of each CCC district and the CSU Trustees and requests that the Regents of the UC email students at the beginning of each semester the location of fentanyl test strips and opioid overdose reversal medication and that each residential advisor and each housing advisor have been trained on the use of opioid overdose reversal medication.
STAFF COMMENTS
- Need for the bill. According to the author, “There has been an increase in opioid-related deaths in California, with reported opioid deaths skyrocketing to 6800 in 2021. Specifically one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to fentanyl overdose.” The author further states, “California continues to fight the war against opioids. SB 367 which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don’t happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed.”
- Naloxone. According to information posted on the CDPH website, Naloxone, a prescription drug, is an opioid antagonist that works almost immediately to reverse an opiate overdose. It further states that Naloxone has few known adverse effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray. Programs to train and equip bystanders such as friends, family, and other non-health-care providers, as well as drug users themselves, have gained momentum as an effective way to respond to and reverse an opioid overdose.
- Statewide Standing Order for Naloxone Distribution. Current law, established by SB 367 (Hurtado, Chapter 218, Statutes of 2022), calls for each health center located on a UC, CSU, or CCC campus to apply for the statewide standing order issued by CDPH and participate in the naloxone distribution project. If approved, health centers are to distribute the medication according to the project’s terms and conditions. The statewide standing order issued by CDPH allows organizations and entities, including colleges and universities, to distribute naloxone to a person at-risk of experiencing an overdose or an individual in a position to assist a person at-risk. Staff of community organizations and other entities distributing naloxone under the statewide standing order are required to receive training and are also required to train individuals who receive naloxone from them. Organizations, including colleges, may apply to use the statewide standing order and meet certain terms and conditions. A separate distribution program administered through the CDHS allows universities and colleges to apply for and obtain Naloxone at no cost to the institution. As of March 2024, the data collected by the CDHS shows that 10,973 applications were approved for free naloxone. 1,865 of the approved applicants were identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 went to schools or colleges.
- Administration of the medication is not required. This bill attempts to ensure that students who are living in college-affiliated housing facilities have access to medication on site at those facilities. The naloxone distribution project’s terms and conditions would still apply. Although residential advisors and house managers are required to keep the overdose reversal medication on hand as prescribed, the bill does not require them to administer it to students. The bill stipulates that if they choose to administer the medication, the institution will not impose any disciplinary actions for drug-related violations of the student conduct code policy during the incident. As mentioned, under the Naloxone Distribution Project, entities distributing naloxone are required to train individuals who receive naloxone from them on opioid overdose prevention and treatment. Recipient entities are required to report to CDPH the number of known reversals that occurred due to naloxone distribution. This bill would require that campus health centers ensure the training of residential advisors and housing managers, and notify students about their training.
- Status on implementation. According to the Assembly Committee analysis, in response to SB 367, (Hurtado, Chapter 218, Statutes of 2022) CDPH created a toolkit for colleges and universities to use to be in compliance with existing law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use Narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering naloxone under Health and Safety Code Section 1799.102.
Each of the CSU, UC, and 92 CCC campuses has a designated campus health center. The CSU provides educational materials that include the location of naloxone on campus through various methods, including information on the campus website and during orientation. Since 2023, collectively, the 23 campuses of the CSU have provided 5,489 doses of naloxone. Within the CCC system, how naloxone is distributed varies from campus to campus, with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others, such as Cerritos College, have naloxone available at 11 different locations on campus, including the Child Development Center, the Pool, and the Learning Resource Center.
- Previous legislation.
AB 461 (Ramos, Chapter 525, Statutes of 2023) required the CCC and CSU and requests the UC, to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
SB 367 (Hurtado, Chapter 219, Statutes of 2022) established the Campus Opioid Safety Act, which required each CCC and CSU and requests the UC, to provide educational and preventive information about opioid overdose and the use and location of opioid overdose reversal medication on campus during campus orientations.
SUPPORT
Generation Up (Sponsor)
American Academy of Pediatrics, California
California Federation of Teachers
Faculty Association of California's Community Colleges
OPPOSITION
None received
-- END --
Date of Hearing: April 10, 2024
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 1841
Author:(Weber) – As Amended Ver:March 6, 2024
Policy Committee: | Higher Education | Vote: | 11 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: Yes
SUMMARY:
This bill requires health centers on California Community College (CCC) campuses and California State University (CSU) campuses, and requests health centers on University of California (UC) campuses, to provide two doses of opioid overdose reversal medication to each residential advisor in housing facilities and each house manager of sorority and fraternity housing.
Specifically, the medication, known as naloxone hydrochloride (naloxone), is to be obtained through the Naloxone Distribution Project (NDP), administered by the California Department of Public Health (CDPH). In addition, the bill requires the CCC and CSU, and requests the UC, to notify students of the presence and location of the medication at the beginning of each academic semester or term.
FISCAL EFFECT:
- Minor and absorbable ongoing General Fund costs to CSUs and UCs to procure the naloxone through the NDP, provide it to the appropriate points of contact, and periodically notify students of the naloxone’s location.
- Minor and absorbable ongoing Proposition 98 General Fund costs to CCCs to procure the naloxone through the NDP, provide it to the appropriate points of contact, and periodically notify students of the naloxone’s location.
The state would need to reimburse these costs to CCCs, if the Commission on State Mandates determines the bill’s requirements to be a reimbursable state mandate.
- Minor and absorbable ongoing General Fund costs to CDPH.
COMMENTS:
- Background. Naloxone is an over the counter opioid overdose reversal medication. The medication works almost immediately to reverse opiate overdose and has few known adverse effects and has no potential for abuse. The medication can be rapidly administered, typically through intramuscular injection or nasal spray.
CDPH administers NDP. NDP provides free naloxone to various eligible entities, including schools, colleges and universities, community organizations, and first responders.
SB 367 (Hurtado), Chapter 218, Statutes of 2022, requires CCCs and the CSU, and requests the UC, to utilize the NDP to distribute naloxone to students, and to provide educational and preventive information about opioid overdose and reversal medication.
According to the “Assembly Budget Committee Floor Report of the 2023-24 Budget,” the budget includes funding to CDPH for the NDP. Specifically, the budget includes an increase of $42.8 million in the 2023-24 budget year, $12.8 million annually in the 2024-25 and 2025-26 budget years, and $12.1 million in the 2026-27 budget year, all from the Opioid Settlements Fund to expand the distribution of naloxone through NDP. The budget also includes language authorizing the backfilling of certain reductions to the program with Opioid Settlement Fund dollars once they become available.
- Prior Legislation. AB 461 (Ramos), Chapter 525, Statutes of 2023, requires the CCC and CSU, and requests the UC, to provide information about the use and location of fentanyl test strips and to notify students of the presence and location of fentanyl test strips, and requires each campus health center to stock and distribute fentanyl test strips.
Analysis Prepared by: Natasha Collins / APPR. / (916) 319-2081
Date of Hearing: March 12, 2024
ASSEMBLY COMMITTEE ON HIGHER EDUCATION
Mike Fong, Chair
ABPCA Bill Id:AB 1841 (
Author:Weber) – As Amended Ver:March 06, 2024
SUBJECT: Student safety: opioid overdose reversal medication: student housing facilities
SUMMARY: Requires health centers on campus of the California Community College (CCC), California State University (CSU) to provide two doses of opioid overdose reversal medication to each residential advisor in housing facilities and each house manager of sorority and fraternity housing on campuses of the California Community College (CCC), California State University (CSU), so that the residential advisors and house managers have the medication either in their room or on-their-person while on-call. Requests the health centers located on campuses of University of California (UC) to do the above. Specifically, this bill:
- Requires the governing board of a CCC and the Board of Trustees of the CSU and requests the Regents of the UC to email students the location of fentanyl test strips and opioid overdose reversal medication at the beginning of each semester or academic term.
- Requires the health center, located on a CCC, or CSU campus and requests a health center on a UC campus, who has applied and received federally approved overdose reversal medication through the Naloxone Distribution Project, to distribute two doses of the medication annually, in accordance with the terms and conditions of the Naloxone Distribution Project, to the following entities:
- Residential advisors or the equivalent position of the college-affiliated student housing facility. The residential advisor will keep the medication on their person while on call or in their room. The residential advisor is not required to administer the medication and if, the residential advisor administers the medication, a student who may have been found to have violated the student code of conduct due to the reversal incident, will not receive disciplinary sanctions from the campus.
- House managers or the equivalent position, of college-affiliated sorority or fraternity housing facilities. The house manager will keep the medication on their person while on call or in their room. The house manager is not required to administer the medication and if, the house manager administers the medication, a student who may have been found to have violated the student code of conduct due to the reversal incident, will not receive disciplinary sanctions from the campus.
EXISTING LAW:
- Requires the governing board of each CCC district and the Trustees of the CSU, and requests the Regents of the UC to do the following:
- Collaborate with campus-based and community-based recovery advocacy organization to provide educational and prevention information provided by the State Department of Public Health about opioid overdose during the campus orientation. The educational and prevention materials should include information about the location of fentanyl test strips and opioid overdose reversal medication on campus.
- Notify students of the presences and location of fentanyl test strips via email.
- Have each campus health center do the following:
- Apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication and to participate in the Naloxone Distribution Project;
- If approved, distribute the federally approved opioid overdose medication in accordance with the terms and conditions of the State Department of Health Care Services;
- Stock and distribute fentanyl strips with written instruction on how to properly use the fentanyl test strips (Education Code Section 67384).
FISCAL EFFECT: Unknown
COMMENTS: Need for the measure. As depicted by the author of the measure, “California continues to fight the war against opioids. SB 367 (Hurtado), Chapter 218, Statute of 2022, which required college campuses Health Centers to distribute approved opioid overdose reversal medication. While this is helpful in the fight against opioid overdoses, if a student does not have the medication, it can be difficult and timely to find and use the opioid overdose reversal medication. AB 1841 would require Residential advisors be trained and have access to the opioid overdose reversal medication in dorms and for school affiliated Greek housing to have possession of these medication as well. Opioid overdoses don’t happen at the health center, they are more likely to occur where the students spend the majority of their free time. AB 1841 would save lives by placing the opioid overdose reversal medication where it is needed.”
Naloxone Statewide Standing Order. SB 635 (Ammiano), Chapter 707, Statute of 2013, expanded, to all 58 counties in California, a successful pilot program that permitted qualified licensed health care providers to either prescribe an opioid antagonist to a person at risk of an overdose or to provide an opioid antagonist to other persons in a position to assist the at-risk individual from overdosing. In addition to providing training on how to administer the antagonist, the provision provided qualified immunity from civil liability, criminal prosecution and professional review to both the licensed health care providers and anyone who administers the antagonist. The changes to the code section provided the legal jurisdiction for the California State Department of Public Health (CDPH) to issue a statewide Naloxone Standing Order in 2017.
The Naloxone Statewide Standing Order, allowed 1) community organizations, schools, universities, and a host of other organizations to distribute naloxone (opioid antagonist) to either a person at risk of an opioid-related overdose, or to a family member, friend, or other person in a position to assist the at-risk person; and, 2) allowed the recipient of the naloxone to administer the antagonist to a person experiencing or reasonably suspected of experiencing an opioid overdose.
The Naloxone Statewide Standing Order was established to reduce the number of deaths associated with an opioid overdose through community action. Community organizations could apply for a “permit” to distribute naloxone by agreeing to the terms and conditions set forth by the CDPH.
The terms and conditions require the recipient entity of the naloxone to train individuals on how to use the drug and require the entities to report back to the CDPH the number of known reversals that occurred due to the distribution of naloxone. CDPH created a publicly accessible training video that demonstrates:
- How to prevent an overdose;
- How to recognize an opioid overdose, including how to check responsiveness;
- How to store and administer the naloxone;
- How to administer rescue breathing;
- How to place the subject tin the recovery position; and,
- How to provide post-overdose care.
The video is readily assessable on CDPH website and is also on YouTube. The Naloxone Standing Order for narcan naloxone nasal spray (narcan) is no longer required because as of March 29, 2023 the U.S. Food and Drug Administration approved narcan for over the counter dispersal. Since a prescription is no longer required, entities no longer need the standing order to distribute narcan to the general public. Other forms of naloxone including intramuscular naloxone, which is administered via a needle to the thigh, still require approval under the Naloxone Statewide Standing Order. As of August 2020, all 50 states and the District of Columbia have some form of naloxone access laws that help citizens access the overdose reversal medication.
The Naloxone Distribution Project. After applying for the standing order, entities were encouraged by CDPH to apply for free naloxone from the California Department of Healthcare Services (CDHS) through the Naloxone Distribution Project. The CDHS created the Naloxone Distribution Project in October 2018 to work in tandem with the Naloxone Statewide Standing Order to combat opioid overdose-related deaths. The funding for the project is received through the State General Funds and from monetary settlements with Janssen and Distributors Settlement Agreements. In the 2023-2024 budget, the State increased budget funding for the project by $74.75 million. Since its inception, the Naloxone Distribution Project has distributed more than 3 million naloxone kits which have saved more than 250,000 lives.
Entities are able to apply for the free naloxone and can receive shipments of up to 2,400 units from CDHS. For orders larger than 204 units, the applying entity must provide a distribution plan and a comprehensive summary justifying the need for the large order. Just as with the standing order, entities who receive the free naloxone, must provide training on how to use the drug to properly reverse the effect of the opioid and report information regarding the number of known reversals that occur from the distribution of the naloxone. Just as with the statewide standing order, the CDHS provides access to free online trainings for how to use the naloxone provided by the program.
Data collected by the CDHS shows that as of March 2024, 10,973 applications have been approved for free naloxone. 1,865 of those approved applicants identified as either schools or colleges. Of the 3,887,536 doses of naloxone provided, 194,376 were provided to schools or colleges.
Campus Opioid Safety Act. SB 367 (Hurtado) established the Campus Opioid Safety Act which required CCC and CSU and requested the UC to do the following:
- Provide educational and prevention information provided by the CDPH about opioid overdose and the use and location of naloxone on campuses during campus orientations; and,
- Have the campus health centers apply for a permit to distribute naloxone through the Naloxone Statewide Standing Order and if approved, subsequently apply to Naloxone Distribution Project to provide free naloxone to the campus community.
In response to the Campus Opioid Safety Act, the CDPH created a toolkit for colleges and universities to use to be in compliance with the law. The toolkit includes a video on naloxone, fact sheets on opioid overdose prevention on college campuses, a video on how to use narcan (nasal spray naloxone), and social media campaigns to help advertise the availability of the naloxone on campus. The CDPH website dedicated to College Opioid Overdose Prevention includes information on California Good Samaritan Laws and encourages campuses to inform students of their protection from being liable for any civil damages for administering the naloxone under Health and Safety Code Section 1799.102.
Each of the CSU and UC campuses have a designated campus health centers. The CSU provides educational materials that include the location of naloxone on campus through various methods including information on the campus website and during orientation. Since 2023, collectively the 23 campuses of the CSU have provided 5,489 doses of naloxone.
At the time of the publication of this analysis, Committee Staff had not received information from the UC office of the president on whether they have required campuses to comply with AB 367 (Hurtado). A search of UC campus websites yielded a confusing result with each campus seemingly having their own distribution plan with some partnering with nonprofit organizations and other offering naloxone through the campus health center.
The CCC does not require students to attend orientation even if one is offered on campus; therefore it is impossible to confirm if CCC students are receiving the educational materials as intended by Senator Hurtado. 92 community colleges have a health center on campus. How naloxone is distributed varies from campus to campus with some providing naloxone directly from the health center or from campus security and others holding publicly available trainings where students can pick up a naloxone kit after they complete the training. Others such as Cerritos College have naloxone available at 11 different locations on campus including the Child Development Center, the Pool, and the Learning Resource Center.
At the time of the publication of this analysis the Chancellor’s Office of the CCC could not confirm the number of community colleges who had applied for the standing order nor who had applied to receive naloxone through the Naloxone Distribution Project.
Furthermore, according to the Chancellor’s Office, concerns have been raised by some community colleges regarding whether they are able to adhere to the terms and conditions set forth by the Naloxone Distribution Project and therefore have elected not to apply. Specifically concerns were raised as to whether the community colleges could comply with reporting opioid overdose reversals. How can the CCC do this is they are providing the naloxone to students who could use the medication on-and off-campus? The answer to their question lies in the application for the Naloxone Distribution Project which clearly states the entity is required to report known or available data on the number of reversals. Therefore, if the community college were to provide the medication to students and no data is reported back to the college on whether the naloxone was used, the community college would not be required to report data to CDHS. Another concern raised by some community colleges was the fear of liability lawsuits. This concern is covered by the CDPH website dedicated to College Opioid Overdose Prevention. Community college staff who administer the lifesaving naloxone would not be liable under the Good Samaritan laws.
Committee Staff note that regardless of the liability concerns they are bound by state law to apply and if approved, to provide the naloxone medication through their campus health centers. A community college could avoid compliance only if the college does not have a health center on campus.
College housing and residential advisors. The U.S. Bureau of Labor Statistics (Bureau) defines residential advisors as employees of a college or university that coordinate activities, order supplies, determine need for maintenance, repairs, and furnishings, and assists residents of the facility with resolving problems of a relational or academic nature by either direct assistance or referrals to supports on campus. The Bureau, as of May 2022, found that 9,030 colleges, universities, and professional schools employed residential advisors and the average hourly pay of $20.24.
The UC and CSU both have housing on each of their campuses and have designated positions similar to a residential advisor, although the nomenclature of the position differs from campus to campus. Typically, residential advisors are student-employees of the campus, who live within the dorms, monitor residential activities, and provide emotional and if necessary, health support to the residents. Each campus has their own training for residential advisors which in some cases includes campus safety protocols, cardiopulmonary resuscitation, and conflict resolution.
Thirteen community college campuses have student housing. All but three have residential advisors or the equivalent positions for the on-campus housing.
The UC and CSU both have Greek fraternity and sorority affiliations on campus and in some cases, the fraternity or sorority have designated housing on campus. The CCC, however, do not have campus-affiliated fraternities and sororities. The Greek life on CCC is relegated to clubs; however it is possible with the increase in student housing and the offering of baccalaureate degrees on CCC campuses, fraternity and sorority participation may increase beyond club status.
Arguments in support. Generation Up, a student-led educational advocacy organization dedicated to amplifying youth voices, heralds the need for AB 1841, because, “one out of every five Californian youth aged 15 to 24 tragically passed away in 2021 due to opioid overdose. Training residential life staff on Naloxone administration and stocking university-affiliated housing facilities, like dormitories and apartments, with said opioid overdose reversal medication would allow for the administration of life-saving medication in the most timely manner. By providing students with resources, training, and education to harm reduction, campuses can be made safer and lower the risk of overdose-related death.”
Previous legislation.
- AB 461 (Ramos), Chapter 525, Statutes of 2023, requires the CCC and CSU and requests the UC, to provide information about the use and location of fentanyl test strips as part of established campus orientations, to notify students of the presence and location of fentanyl test strips, and requires that each campus health center stock and distribute fentanyl test strips, as specified.
- SB 367 (Hurtado), Chapter 219, Statutes of 2022, established the Campus Opioid Safety Act, which required each CCC and CSU and requests the UC, to provide educational and preventive information about opioid overdose and the use and location of opioid overdose reversal medication on campus during campus orientations.
REGISTERED SUPPORT / OPPOSITION:
Support
California Association of Alcohol and Drug Program Executives, INC.
California District Attorneys Association
Faculty Association of California Community Colleges
Genup (generation Up)
Opposition
None on file.
Analysis Prepared by: Ellen Cesaretti-Monroy / HIGHER ED. / (916) 319-3960
Bill Author
Bill Co-Author(s):